G. Ramesh1, S. Sandeep Kumar2, Shalini N. Swamy3, C. S. Premalata4, V. R. Pallavi5
PURPOSE: The promoter hypermethylation patterns of Thrombospodin-1 gene in 50 EOC patients were studied and the methylation pattern was correlated with various clinic pathological parameters.
METHODS: The promoter hypermethylation pattern of the TSP-1 gene was assessed using nested PCR and Methylation specific PCR.
STATISTICAL ANALYSIS: All the available data was statistically analyzed using the Chi square test or Fisher Exact Test on the SPSS software version 22.0 and a value <0.05 was considered statistically significant.
RESULTS: Forty of the fifty ovarian carcinoma samples reported positive for methylation corresponding to a methylation frequency of 80%. A methylation frequency of 89.2%, 83.3% and 42.8% was observed in malignant, Low malignant potential (borderline) and benign sample cohorts.
CONCLUSION: From the results drawn from this study, it clearly shows that the anti angiogenic protein TSP-1 is extensively hypermethylated in ovarian carcinoma and that it accumulates over the progression of the disease from benign to malignant. As previous reports suggest that there is no evidence of mutation of this gene, promoter hypermethylation may be a crucial factor for the down regulation of the gene. Further by clubbing together the promoter hypermethylation pattern of TSP-1 gene with hypermethylation patterns of other TSG may provide a better insight into the application of using methylation profiles of TSG as a biomarker in the detection of ovarian carcinoma.